Skip to main content

SLC7A1 KO cell line available to order. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 3 and 35 bp deletion in exon 3.

Be the first to review this product! Submit a review

Images

Sanger Sequencing - Human SLC7A1 (CAT1) knockout HEK-293T cell line (AB266234), expandable thumbnail
  • Sanger Sequencing - Human SLC7A1 (CAT1) knockout HEK-293T cell line (AB266234), expandable thumbnail

Key facts

Cell type
HEK-293T
Species or organism
Human
Tissue
Kidney
Form
Liquid
Knockout validation
Sanger Sequencing
Mutation description
Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 3 and 35 bp deletion in exon 3

Alternative names

Recommended products

SLC7A1 KO cell line available to order. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 3 and 35 bp deletion in exon 3.

Key facts

Cell type
HEK-293T
Form
Liquid
Mutation description
Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 3 and 35 bp deletion in exon 3
Concentration
Loading...

Properties

Gene name
SLC7A1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing

Quality control

STR analysis
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level
EU: 2 US: 2
Adherent/suspension
Adherent
Gender
Female

Handling procedures

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium
DMEM (High Glucose) + 10% FBS
Cryopreservation medium
Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Storage

Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Notes

Recommended control: Human wild-type HEK293T cell line (ab255449). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.
Activity summary

CAT1 also known as cationic amino acid transporter 1 or SLC7A1 is an integral membrane protein that facilitates the uptake of cationic amino acids such as arginine lysine and ornithine. CAT1 is a member of the solute carrier family 7 and has a molecular mass of approximately 68 kDa. It expresses widely in various tissues with particularly high levels in the liver lung and skeletal muscle. As a transporter CAT1 plays an essential role in amino acid homeostasis by mediating amino acid transport across the cell membrane.

Biological function summary

CAT1 influences nitric oxide production by regulating arginine availability a substrate for nitric oxide synthase. By controlling amino acid imports it affects cellular signaling and metabolism. CAT1 does not function as part of a larger complex but interacts with other transporters to maintain cellular amino acid balance. CAT1's role extends to impacting cell proliferation as cationic amino acids are important for growing tissues.

Pathways

CAT1 has been implicated in the nitric oxide synthesis pathway where it contributes by sustaining intracellular arginine levels. This involvement is critical to vascular function and immune response regulation. CAT1 also participates in mTOR signaling by providing necessary amino acids like arginine which influence protein synthesis and cellular growth. In these pathways CAT1 connects with proteins such as mTOR and nitric oxide synthase assisting in integral cellular functions.

Associated diseases and disorders

CAT1 links to cardiovascular conditions through its role in nitric oxide production which affects blood pressure regulation and endothelial function. Dysfunction or altered expression of CAT1 can lead to cardiovascular abnormalities due to impaired nitric oxide synthesis. CAT1 is also implicated in cancer as its impact on arginine availability affects cell proliferation and tumor growth. In this context CAT1 interacts with oncogenes and tumor suppressor proteins that modulate growth-related pathways.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

2 product images

  • Sanger Sequencing - Human SLC7A1 (CAT1) knockout HEK-293T cell line (ab266234), expandable thumbnail

    Sanger Sequencing - Human SLC7A1 (CAT1) knockout HEK-293T cell line (ab266234)

    Allele-2: 1 bp insertion in exon 3.

  • Sanger Sequencing - Human SLC7A1 (CAT1) knockout HEK-293T cell line (ab266234), expandable thumbnail

    Sanger Sequencing - Human SLC7A1 (CAT1) knockout HEK-293T cell line (ab266234)

    Allele-1: 35 bp deletion in exon3

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com